R&D Pipeline

Pipeline (2021-2030)

Metabolic - Other-Bio. (1)

Modality Indication Targets Stage Company Project No. Detail
1 Development of Treatment Drugs for Obesity using Concomitant Administration of Microbiome Consortia
Other-Bio. Obesity Bacteroides vulgatus, Roseburia intestinalis, Akkermansia muciniphila Candidate KoBiolabs Inc. RS-2023-00219249